{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T16:30:32Z","timestamp":1793205032751,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100016345","name":"Renmin Hospital of Wuhan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016345","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jbc.2025.108155","type":"journal-article","created":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T16:30:09Z","timestamp":1736008209000},"page":"108155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Unveiling ADAMTS12: A key driver of bladder cancer progression via COL3A1-Mediated activation of the FAK\/PI3K\/AKT signaling pathway"],"prefix":"10.1016","volume":"301","author":[{"given":"Jian-hua","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-zhe","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-zhuo","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2025.108155_bib1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jbc.2025.108155_bib2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jbc.2025.108155_bib3","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.7150\/ijbs.74546","article-title":"PHGDH inhibits ferroptosis and promotes malignant progression by upregulating SLC7A11 in bladder cancer","volume":"18","author":"Shen","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.jbc.2025.108155_bib4","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer: a review","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jbc.2025.108155_bib5","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1158\/0008-5472.CAN-22-2485","article-title":"The m6A reader YTHDF2 promotes bladder cancer progression by suppressing RIG-I-mediated immune response","volume":"83","author":"Zhang","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2025.108155_bib6","doi-asserted-by":"crossref","first-page":"e341","DOI":"10.1016\/S1470-2045(17)30327-3","article-title":"Evolving adoptive cellular therapies in urological malignancies","volume":"18","author":"Wong","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jbc.2025.108155_bib7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13045-022-01312-5","article-title":"Allosteric activation of the metabolic enzyme GPD1 inhibits bladder cancer growth via the lysoPC-PAFR-TRPV2 axis","volume":"15","author":"Zhang","year":"2022","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.jbc.2025.108155_bib8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13059-015-0676-3","article-title":"The ADAMTS (A disintegrin and metalloproteinase with thrombospondin motifs) family","volume":"16","author":"Kelwick","year":"2015","journal-title":"Genome Biol."},{"key":"10.1016\/j.jbc.2025.108155_bib9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.hbpd.2022.04.005","article-title":"ADAMTS12 promotes migration and epithelial-mesenchymal transition and predicts poor prognosis for pancreatic cancer","volume":"22","author":"He","year":"2023","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.jbc.2025.108155_bib10","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.AAC118.004590","article-title":"ADAMTS-12 metalloprotease is necessary for normal inflammatory response","volume":"293","author":"Moncada-Pazos","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2025.108155_bib11","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1038\/onc.2010.49","article-title":"Higher sensitivity of adamts12-deficient mice to tumor growth and angiogenesis","volume":"29","author":"El Hour","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2025.108155_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110866","article-title":"ADAMTS12 promotes oxaliplatin chemoresistance and angiogenesis in gastric cancer through VEGF upregulation","volume":"111","author":"Jiang","year":"2023","journal-title":"Cell Signal."},{"key":"10.1016\/j.jbc.2025.108155_bib13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/odi.14403","article-title":"ADAMTS12, a novel prognostic predictor, promotes cell proliferation, migration, and invasion in head and neck squamous cell carcinoma","volume":"30","author":"Li","year":"2024","journal-title":"Oral Dis."},{"key":"10.1016\/j.jbc.2025.108155_bib14","doi-asserted-by":"crossref","first-page":"636","DOI":"10.6004\/jnccn.2018.0051","article-title":"The changing treatment landscape for metastatic urothelial carcinoma","volume":"16","author":"Flaig","year":"2018","journal-title":"J.\u00a0Natl. Compr. Canc Netw."},{"key":"10.1016\/j.jbc.2025.108155_bib15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12957-023-03128-0","article-title":"GREM1 is a potential biomarker for the progression and prognosis of bladder cancer","volume":"21","author":"Jiang","year":"2023","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.jbc.2025.108155_bib16","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.eururo.2020.07.002","article-title":"FGFR3 mutation status and FGFR3 expression in a large bladder cancer cohort treated by radical cystectomy: implications for anti-FGFR3 treatment?\u2020","volume":"78","author":"van Rhijn","year":"2020","journal-title":"Eur. Urol."},{"key":"10.1016\/j.jbc.2025.108155_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102530","article-title":"Role of FGFR3 in bladder cancer: treatment landscape and future challenges","volume":"115","author":"Ascione","year":"2023","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.jbc.2025.108155_bib18","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.3390\/ijms24043720","article-title":"HER2 expression in bladder cancer: a focused view on its diagnostic, prognostic, and predictive role","volume":"24","author":"Sanguedolce","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2025.108155_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.matbio.2015.04.005","article-title":"Metalloproteinases: a parade of functions in matrix biology and an outlook for the future","volume":"44-46","author":"Apte","year":"2015","journal-title":"Matrix Biol."},{"key":"10.1016\/j.jbc.2025.108155_bib20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s12672-023-00776-2","article-title":"Effects of metalloprotease ADAMTS12 on cervical cancer cell phenotype and its potential mechanism","volume":"14","author":"Zou","year":"2023","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.jbc.2025.108155_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90330-3","article-title":"ADAMTS12 acts as a tumor microenvironment related cancer promoter in gastric cancer","volume":"11","author":"Hou","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2025.108155_bib22","first-page":"56","article-title":"MicroRNA-186 suppresses cell proliferation and metastasis in bladder cancer","volume":"22","author":"Liang","year":"2022","journal-title":"Afr. Health Sci."},{"key":"10.1016\/j.jbc.2025.108155_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.856560","article-title":"The LINC01929\/miR-6875-5p\/ADAMTS12 Axis in the ceRNA network regulates the development of advanced bladder cancer","volume":"12","author":"Xiong","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.jbc.2025.108155_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.mvr.2011.05.004","article-title":"Heterotrimeric G proteins, focal adhesion kinase, and endothelial barrier function","volume":"83","author":"Thennes","year":"2012","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.jbc.2025.108155_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12943-024-01944-w","article-title":"ZNF460-mediated circRPPH1 promotes TNBC progression through ITGA5-induced FAK\/PI3K\/AKT activation in a ceRNA manner","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jbc.2025.108155_bib26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12935-023-03073-8","article-title":"FAP promotes clear cell renal cell carcinoma progression via activating the PI3K\/AKT\/mTOR signaling pathway","volume":"23","author":"Jiang","year":"2023","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.jbc.2025.108155_bib27","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/molecules23010058","article-title":"Flaccidoxide-13-Acetate extracted from the soft coral cladiella kashmani reduces human bladder cancer cell migration and invasion through reducing activation of the FAK\/PI3K\/AKT\/mTOR signaling pathway","volume":"23","author":"Neoh","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.jbc.2025.108155_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-46091-2","article-title":"Human amniotic membrane inhibits migration and invasion of muscle-invasive bladder cancer urothelial cells by downregulating the FAK\/PI3K\/Akt\/mTOR signalling pathway","volume":"13","author":"Janev","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2025.108155_bib29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.gene.2019.05.003","article-title":"Type III collagen (COL3A1): gene and protein structure, tissue distribution, and associated diseases","volume":"707","author":"Kuivaniemi","year":"2019","journal-title":"Gene"},{"key":"10.1016\/j.jbc.2025.108155_bib30","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s12094-021-02734-2","article-title":"Cancer-associated fibroblasts in colorectal cancer","volume":"24","author":"Kamali Zonouzi","year":"2022","journal-title":"Clin. Transl Oncol."},{"key":"10.1016\/j.jbc.2025.108155_bib31","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1515\/med-2022-0436","article-title":"Radiation increases COL1A1, COL3A1, and COL1A2 expression in breast cancer","volume":"17","author":"Yao","year":"2022","journal-title":"Open Med. (Wars)"},{"key":"10.1016\/j.jbc.2025.108155_bib32","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1186\/s12885-022-09736-5","article-title":"Comprehensive bioinformatic analysis reveals a cancer-associated fibroblast gene signature as a poor prognostic factor and potential therapeutic target in gastric cancer","volume":"22","author":"Ucaryilmaz Metin","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jbc.2025.108155_bib33","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1002\/cam4.5170","article-title":"COL3A1: potential prognostic predictor for head and neck cancer based on immune-microenvironment alternative splicing","volume":"12","author":"Shen","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.jbc.2025.108155_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-44459-y","article-title":"Identification of GUCA2A and COL3A1 as prognostic biomarkers in colorectal cancer by integrating analysis of RNA-Seq data and qRT-PCR validation","volume":"13","author":"Hosseini","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2025.108155_bib35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1158\/1541-7786.MCR-23-0512","article-title":"RNF185 control of COL3A1 expression limits prostate cancer migration and metastatic potential","volume":"22","author":"Van Espen","year":"2024","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.jbc.2025.108155_bib36","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1002\/cbin.11875","article-title":"Silencing of COL3A1 represses proliferation, migration, invasion, and immune escape of triple negative breast cancer cells via down-regulating PD-L1 expression","volume":"46","author":"Yang","year":"2022","journal-title":"Cell Biol. Int."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192582500002X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192582500002X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T20:08:29Z","timestamp":1740514109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002192582500002X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S002192582500002X"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2025.108155","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unveiling ADAMTS12: A key driver of bladder cancer progression via COL3A1-Mediated activation of the FAK\/PI3K\/AKT signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2025.108155","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology\u00e9","name":"copyright","label":"Copyright"}],"article-number":"108155"}}